Study limitation: Level of evidence assigned as '4' based on cross-sectional design, but this is an estimate pending full-text review | ReachRx
Prevalence of LDL-C Above 2026 Dyslipidemia Guideline Goals Among US Adults
Study limitation reported by the research below: “Level of evidence assigned as '4' based on cross-sectional design, but this is an estimate pending full-text review.”
